L
Luca Jaromi
Researcher at University of Pécs
Publications - 33
Citations - 860
Luca Jaromi is an academic researcher from University of Pécs. The author has contributed to research in topics: Population & Allele frequency. The author has an hindex of 15, co-authored 33 publications receiving 773 citations.
Papers
More filters
Journal ArticleDOI
Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis
Bernadett Faragó,Lili Magyari,Eniko Safrany,Veronika Csöngei,Luca Jaromi,Katalin Horvatovich,Csilla Sipeky,Anita Maász,Judit Radics,Ágnes Gyetvai,Zoltán Szekanecz,László Czirják,Béla Melegh +12 more
TL;DR: There is direct evidence that some allelic variants or haplogroups of IL-23R represent independent risk factors for rheumatoid arthritis as well as Crohn’s disease, but not for scleroderma.
Journal ArticleDOI
WNT signaling – lung cancer is no exception
TL;DR: The various effects of activation and inhibition of the WNT signaling pathways are summarized in the context of lung carcinogenesis and the role of WNT ligand transport mechanisms is reviewed.
Journal ArticleDOI
Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples.
Enikő Sáfrány,B. Pazár,Veronika Csöngei,Luca Jaromi,Noémi Polgár,Csilla Sipeky,Ildikó Horváth,Margit Zeher,G. Poór,Béla Melegh +9 more
TL;DR: The susceptibility or protective associations of IL23R polymorphisms with AS in a Hungarian population are confirmed and the involvement of the rs11805303 intronic single nucleotide polymorphisms, which was tested so far only for other autoimmune diseases is demonstrated.
Journal ArticleDOI
Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome.
Anita Maász,Péter Kisfali,Katalin Horvatovich,Márion Mohás,Lajos Markó,Veronika Csöngei,Bernadett Faragó,Luca Jaromi,Lili Magyari,Enikő Sáfrány,Csilla Sipeky,István Wittmann,Béla Melegh +12 more
TL;DR: Findings strongly suggest that this variant of the ApoA5 –1131C gene is a risk factor for the development of hypertriglyceridemia and metabolic syndrome.
Journal ArticleDOI
ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.
M. Vesel,Judit Rapp,D. Feller,E. Kiss,Luca Jaromi,Matyas Meggyes,Gyorgy Miskei,B. Duga,Gabor Smuk,Terézia László,Ivan Karner,Judit E. Pongracz +11 more
TL;DR: The difference in the Wnt microenvironment in AC and SCC leads to variations in ABC transporter expression, and cisplatin, the frequently used adjuvant chemotherapeutic agent, activated beta-catenin dependent signaling that lead to up-regulation of both ABCB1 and ABCG2 transporter expression and activity.